MedCity News: Can Gamification Impact Adherence for People with Diabetes?

12/11/2013

Stephanie Baum writes in MedCity News:

Merck (NYSE: MRK) is turning to gamification in a collaboration with Canadian gaming developer Ayogo in a bid to support adherence.

It was one of a group of companies demonstrating their games in the Games for Health Pavillion at the mHealth Summit this week near Washington, D.C.

“Our goal is to help diabetics get their condition under control.” Ayogo CEO Michael Fergusson said. “Users feel like they are getting gold for having fun but really they get it for engagement.”

Fergusson has collaborated with other pharmaceutical companies, such as Sanofi-Aventis.

The game has been the subject of two pilots with academic partners with a third underway.